Isolation, Synthesis, and Characterization of CD47- and Integrin α4/β1-Modified Macrophage Membrane-Coated...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Research

Background:

• Atherosclerosis is a chronic inflammatory disease causing significant cardiovascular issues.
• Effective targeted delivery of anti-inflammatory drugs to atherosclerotic lesions is a major challenge.
• Biomimetic nanoparticles offer a potential solution for localized drug delivery.

Purpose of the Study:

• To present a detailed protocol for preparing and characterizing CD47- and integrin α4/β1-co-modified macrophage membrane-coated colchicine-loaded poly(lactic-co-glycolic acid) nanoparticles (MMM/COL NPs).
• To provide a robust and scalable method for generating these biomimetic nanoparticles for atherosclerosis research.
• To validate the functional efficacy of MMM/COL NPs in vitro and in vivo.

Main Methods:

• Macrophage modification through plasmid transfection and endothelin-1 stimulation.
• Isolation of macrophage membranes and fabrication of poly(lactic-co-glycolic acid) nanoparticles (NPs).
• Coating of NPs with modified macrophage membranes, followed by comprehensive physicochemical characterization and functional assays.

Main Results:

• Successful preparation and characterization of CD47- and integrin α4/β1-co-modified macrophage membrane-coated NPs.
• Demonstrated enhanced cellular association with activated endothelial cells and increased macrophage uptake.
• Validated anti-inflammatory effects in foam cells and favorable biodistribution in a murine atherosclerosis model.

Conclusions:

• The developed protocol offers a reproducible and scalable approach for generating biomimetic nanoparticles.
• MMM/COL NPs show significant potential for targeted drug delivery in atherosclerosis treatment.
• This method advances the development of nanomedicines for chronic inflammatory diseases.